Holen Sie sich die Stockscreener-App
67.41
2.46%
1.62
Handel nachbörslich:
67.41
Schlusskurs vom Vortag:
$65.79
Offen:
$65.24
24-Stunden-Volumen:
1.27M
Relative Volume:
1.04
Marktkapitalisierung:
$11.69B
Einnahmen:
$8.35B
Nettoeinkommen (Verlust:
$1.56B
KGV:
7.5965
EPS:
8.8738
Netto-Cashflow:
$-4.00M
1W Leistung:
+6.58%
1M Leistung:
+0.97%
6M Leistung:
-4.90%
1J Leistung:
+1.84%
1-Tages-Spanne:
$65.13
$67.45
1-Wochen-Bereich:
$62.38
$67.45
52-Wochen-Spanne:
$62.38
$88.20
Solventum Corp Stock (SOLV) Company Profile
Firmenname
Solventum Corp
Sektor
Telefon
651-733-1110
Adresse
C/O 3M COMPANY, ST. PAUL
Compare SOLV vs ISRG, BDX, ALC, MDLN, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SOLV
Solventum Corp
|
67.41 | 11.41B | 8.35B | 1.56B | -4.00M | 8.8738 |
ISRG
Intuitive Surgical Inc
|
458.96 | 160.05B | 10.06B | 2.88B | 2.49B | 7.876 |
BDX
Becton Dickinson Co
|
155.43 | 43.87B | 21.92B | 1.76B | 2.63B | 6.1223 |
ALC
Alcon Inc
|
79.74 | 38.02B | 10.40B | 980.00M | 1.61B | 1.9749 |
MDLN
Medline Inc
|
47.22 | 37.01B | 28.43B | 1.16B | 1.26B | 1.4457 |
RMD
Resmed Inc
|
230.26 | 33.34B | 5.40B | 1.49B | 1.78B | 10.12 |
Solventum Corp Stock (SOLV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-24 | Eingeleitet | Rothschild & Co Redburn | Sell |
| 2026-01-26 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2026-01-20 | Hochstufung | Mizuho | Neutral → Outperform |
| 2025-12-02 | Hochstufung | BTIG Research | Neutral → Buy |
| 2025-10-01 | Eingeleitet | UBS | Neutral |
| 2025-09-11 | Eingeleitet | Jefferies | Hold |
| 2025-07-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2025-07-01 | Hochstufung | Argus | Hold → Buy |
| 2025-06-06 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2025-05-19 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-10-08 | Eingeleitet | Stifel | Buy |
| 2024-10-07 | Eingeleitet | Piper Sandler | Neutral |
| 2024-09-26 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-09-05 | Eingeleitet | BTIG Research | Neutral |
| 2024-06-24 | Eingeleitet | Argus | Hold |
| 2024-05-30 | Eingeleitet | Goldman | Sell |
| 2024-05-10 | Eingeleitet | BofA Securities | Neutral |
| 2024-04-10 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2024-04-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-04-02 | Eingeleitet | Edward Jones | Hold |
Alle ansehen
Solventum Corp Aktie (SOLV) Neueste Nachrichten
Is Solventum (SOLV) Unlocking Hidden Value With Its MedSurg-Focused Portfolio Simplification Strategy? - simplywall.st
Solventum Corp. stock rises Monday, outperforms market - MarketWatch
Surgical Equipment & ConsumablesDiversified Stocks Q4 Recap: Benchmarking Solventum (NYSE:SOLV) - Yahoo Finance
Market Pulse: Is Solventum Corporation attractive for institutional investorsIndex Update & Free Accurate Trade Setup Notifications - baoquankhu1.vn
Surgical Devices and SuppliesQ4 Review of Diversified Holdings: Comparing Solventum (NYSE:SOLV) to Peers - Bitget
Minnesota’s Solventum to pay $1.6M fine for selling equipment to Chinese firms - MSN
Solventum healthcare company expands its Brookings facility - MSN
Solventum Fined $1.6M Over Sales To Chinese Firms - Hoodline
Solventum Corp. stock rises Thursday, outperforms market - MarketWatch
Here's why Solventum (SOLV) is a strong value stock - MSN
Solventum Corp. stock rises Wednesday, outperforms market - MarketWatch
Article: 3M healthcare spinoff reaches BIS settlement for China shipmentsGIR Just Sanctions - Global Investigations Review
US Commerce settles with Solventum over Entity List sale allegations - MLex
Solventum’s Debt Reduction and Financial Restructuring: Has the Optimistic Outlook Been Fully Valued? - Bitget
Solventum: A Hidden Breakup Story In Healthcare(NYSE:SOLV) - Seeking Alpha
Solventum Corporation (SOLV) stock price, news, quote and history - Yahoo Finance Singapore
Solventum Corp. stock falls Tuesday, underperforms market - MarketWatch
Solventum CAO Retirement Puts Focus On Controls And Execution Risks - Yahoo Finance
Solventum celebrates major expansion in Brookings - Brookings Register
Can Solventum Tackle AI Competition in HIS Market? - Medical Device and Diagnostic industry
Solventum stock maintained at Buy by BTIG on AI impact analysis - Investing.com India
Here's why you should hold Solventum stock in your portfolio now - MSN
Solventum’s US$200 Million Innovation Hub and CAO Transition Might Change The Case For Investing In Solventum (SOLV) - simplywall.st
Solventum Corporation (NYSE:SOLV) Receives Average Rating of "Hold" from Analysts - MarketBeat
SOLV Technical Analysis & Stock Price Forecast - Intellectia AI
The Week in Business: Solventum Opens $200M R&D Facility in Eagan - Mpls.St.Paul Magazine
Solventum Corporation (SOLV) Stock Price, News, Quote & History - Yahoo! Finance Canada
Solventum Corp. stock falls Thursday, underperforms market - MarketWatch
$220M expands Brookings medical device facility - KELOLAND.com
3M health care spinoff Solventum officially opens Eagan Innovation Hub - Pioneer Press
Solventum Corp. stock falls Wednesday, underperforms market - MarketWatch
Solventum Opens $200M R&D Facility in Eagan - Twin Cities Business
Solventum delivers personalized healthcare learning with Adobe - Adobe for Business
SOLV SEC FilingsSolventum Corporation 10-K, 10-Q, 8-K Forms - Stock Titan
Solventum Corp. stock rises Tuesday, outperforms market - MarketWatch
SOLVENTUM CORP SOLVENTUM ORD SH (0AD1.L) income statement - Yahoo Finance UK
Solventum Corporation $SOLV Shares Acquired by SG Americas Securities LLC - MarketBeat
Solventum (SOLV) Q4 2025 adjusted diluted EPS reaches $1.57 on 3.5% organic sales growth - MSN
Solventum (SOLV) Rated Buy by Jefferies After Earnings Beat - Insider Monkey
Solventum CCO Heather Knight set for keynote at DeviceTalks Minnesota - MassDevice
[Form 4] Solventum Corp Insider Trading Activity - Stock Titan
Solventum (SOLV) director converts 6,336 RSUs into 11,484 common shares - Stock Titan
Solventum (NYSE: SOLV) director gains 1,980 shares in RSU exercise - stocktitan.net
Solventum (SOLV) director converts 1,980 RSUs into common stock, holding 5,544 shares - Stock Titan
Solventum (SOLV) director exercises 1,980 RSUs, lifts direct holdings to 5,544 shares - Stock Titan
Solventum (NYSE: SOLV) director settles 1,980 RSUs, now holds 5,544 shares - Stock Titan
Solventum (SOLV) director converts 1,980 RSUs, lifts stake to 5,544 shares - Stock Titan
Director at Solventum (NYSE: SOLV) exercises 1,980 RSUs into stock - Stock Titan
Director at Solventum (SOLV) exercises 1,980 RSUs into common shares - Stock Titan
Solventum (SOLV) director converts 1,980 RSUs into 5,606 total shares - Stock Titan
Solventum (SOLV) director converts 1,980 RSUs into 5,544-share holding - Stock Titan
Finanzdaten der Solventum Corp-Aktie (SOLV)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):